Recent CRL News
- Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing • Business Wire • 04/16/2024 12:00:00 PM
- Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call • Business Wire • 04/12/2024 12:00:00 PM
- Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology • Business Wire • 04/11/2024 12:00:00 PM
- Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics • Business Wire • 04/09/2024 12:00:00 PM
- Charles River to Perform Plasmid Production for Ship of Theseus • Business Wire • 04/04/2024 12:00:00 PM
- Charles River to Perform Plasmid Production for Ship of Theseus • Business Wire • 04/04/2024 12:00:00 PM
- Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 • Business Wire • 04/01/2024 12:00:00 PM
- Charles River Laboratories Publishes 2023 Corporate Citizenship Report • Business Wire • 03/27/2024 12:00:00 PM
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine • Business Wire • 03/21/2024 12:00:00 PM
- Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration • Business Wire • 03/14/2024 12:00:00 PM
- Charles River Laboratories to Present at Barclays Global Healthcare Conference • Business Wire • 03/12/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:42:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 07:34:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:54:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:09:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 05:47:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:37:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 08:14:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 05:42:07 PM
- Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use • PR Newswire (US) • 02/29/2024 07:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:57:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 04:09:04 PM
- Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing • Business Wire • 02/21/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:32:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:28:06 PM
FEATURED Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • Apr 17, 2024 8:00 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM
Kona Gold Beverages, Inc. Acquires Surge Distribution LLC from Loud Beverage Group, Inc. (LBEV) • KGKG • Apr 16, 2024 8:30 AM
Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • BLEG • Apr 16, 2024 8:30 AM